I’ve written a lot about dichloroacetate, a.k.a. DCA (my last post here, along with links to my previous posts), the small molecule drug that burst onto the scene after Evangelos Michelakis of the University of Alberta published a paper in Cancer Cell in January describing strong anti-tumor activity in preclinical models (in this case, a […]
Category: Clinical trials
I’m almost beginning to feel sorry for the mercury militia. Think about it. They’ve been claiming for the past several years that the mercury in the thimerosal used as a preservative in childhood vaccines is a cause of autism. If you believe Generation Rescue, A-CHAMP, SAFEMINDS, and various other activist groups, vaccines are the root […]
Share this:
Never let it be said that Orac doesn’t give the people what they want. Well, most of the time, anyway. What I’m referring to is a recent German study about acupuncture for low back pain that’s been making its way around the media. I had actually been planning on commenting about it yesterday, but Iranian […]
Share this:
Pity poor John Ioannidis. The man does provocative work about the reliability of scientific studies as published in the peer-reviewed literature, and his reward for trying to point out shortcomings in how we as scientists and clinical researchers do studies and evaluate evidence is to be turned into an icon for cranks and advocates of […]
Share this:
Sadly (with regards to vacation) and not-so-sadly (with regards to the events of last week), it’s time to dive headlong back into the “real world” at work, starting with clinic today. It also means it’s time to get back to my favorite hobby (blogging) in a much more regular way, although I will say that […]
